a company, which engages in the provision of clinical stage biotechnology company
Industry Biotechnology
A.I.dvisor tells us that XCUR and VSTM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XCUR and VSTM's prices will move in lockstep.
Ticker / NAME | Correlation To XCUR | 1D Price Change % | ||
---|---|---|---|---|
XCUR | 100% | +2.26% | ||
VSTM - XCUR | 28% Poorly correlated | -1.71% | ||
AMGXF - XCUR | 27% Poorly correlated | N/A | ||
FBRX - XCUR | 26% Poorly correlated | +3.69% | ||
NBY - XCUR | 25% Poorly correlated | -4.86% | ||
ERNA - XCUR | 23% Poorly correlated | -3.61% | ||
More |